GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » Valuation Rank

Straumann Holding AG (XSWX:STMN) Valuation Rank


View and export this data going back to 2001. Start your Free Trial

What is Straumann Holding AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Straumann Holding AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (XSWX:STMN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » Valuation Rank
Comparable Companies
XSWX:ALC XSWX:YPSN XSWX:TECN XSWX:SKAN XSWX:CLTN XSWX:VBSN ISRG XPAR:EL BDX TSE:7741 OCSE:COLO B RMD WST XPAR:DIM TSE:4543 BAX COO HOLX TSE:7733 XTER:AFX
Traded in Other Exchanges
SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK
Address
Peter Merian-Weg 12, Basel, CHE, 4002
Website
https://www.straumann-group.com
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.